Active Biotech's election committee appointed
(Thomson Reuters ONE) -
In accordance with a decision made by the Annual General Meeting held on May
15, 2013, the Election Committee shall comprise the representatives for the
three largest shareholders, as per end of September 2013, and the Chairman of
the Board.
For the 2014 Annual General Meeting, the Election Committee shall propose Board
members and a Chairman of the Board, and fees to Board members and auditors. The
following individuals were appointed representatives for the largest
shareholders and, accordingly, are members of the Election Committee:
Johnny Sommarlund, MGA Holding
Tomas Billing, Nordstjernan
Lennart Johansson, Investor
Under the leadership of the Chairman of the Board, Mats Arnhög, the Election
Committee shall prepare proposals for the Board of Directors that are to be
presented to and decided upon at the Annual General Meeting on May 15, 2014.
Lund, November 11, 2013
Active Biotech AB (publ)
Tomas Leanderson
President and CEO
Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company with
focus on autoimmune/inflammatory diseases and cancer. Projects in pivotal phase
are laquinimod, an orally administered small molecule with unique
immunomodulatory properties for the treatment of multiple sclerosis, tasquinimod
for prostate cancer and ANYARA primarily for the treatment of renal cell cancer.
In addition, laquinimod has concluded Phase II development for Crohn's and
Lupus. The company also has one additional project in clinical development, the
orally administered compound paquinimod (57-57) for systemic sclerosis. Please
visit www.activebiotech.com for more information.
Active Biotech AB
PO Box 724, SE-220 07 Lund
Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00
www.activebiotech.com
Active Biotech is obligated to publish the information contained in this press
release in accordance with the Swedish Securities Market Act. This information
was provided to the media for publication 08:30 am CET on November 11, 2013.
Active Biotech's election committee appointed:
http://hugin.info/1002/R/1741861/585372.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Active Biotech via Thomson Reuters ONE
[HUG#1741861]
Unternehmensinformation / Kurzprofil:
Datum: 11.11.2013 - 08:30 Uhr
Sprache: Deutsch
News-ID 314812
Anzahl Zeichen: 2976
contact information:
Town:
LUND
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 128 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Active Biotech's election committee appointed"
steht unter der journalistisch-redaktionellen Verantwortung von
Active Biotech (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
